- Home
- XBP vs INKT Comparison
XBP vs INKT Comparison
Compare XBP & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBP
- INKT
- Stock Information
- Founded
- XBP N/A
- INKT 2017
- Country
- XBP United Kingdom
- INKT United States
- Employees
- XBP N/A
- INKT N/A
- Industry
- XBP Business Services
- INKT Medicinal Chemicals and Botanical Products
- Sector
- XBP Consumer Discretionary
- INKT Health Care
- Exchange
- XBP Nasdaq
- INKT Nasdaq
- Market Cap
- XBP 27.8M
- INKT 28.5M
- IPO Year
- XBP N/A
- INKT 2021
- Fundamental
- Price
- XBP $1.37
- INKT $0.75
- Analyst Decision
- XBP
- INKT Strong Buy
- Analyst Count
- XBP 0
- INKT 2
- Target Price
- XBP N/A
- INKT $6.50
- AVG Volume (30 Days)
- XBP 2.1M
- INKT 32.0K
- Earning Date
- XBP 11-12-2024
- INKT 11-14-2024
- Dividend Yield
- XBP N/A
- INKT N/A
- EPS Growth
- XBP N/A
- INKT N/A
- EPS
- XBP N/A
- INKT N/A
- Revenue
- XBP $148,144,000.00
- INKT N/A
- Revenue This Year
- XBP N/A
- INKT N/A
- Revenue Next Year
- XBP N/A
- INKT N/A
- P/E Ratio
- XBP N/A
- INKT N/A
- Revenue Growth
- XBP N/A
- INKT N/A
- 52 Week Low
- XBP $0.84
- INKT $0.57
- 52 Week High
- XBP $47.40
- INKT $1.90
- Technical
- Relative Strength Index (RSI)
- XBP 60.78
- INKT 54.46
- Support Level
- XBP $1.02
- INKT $0.74
- Resistance Level
- XBP $1.60
- INKT $0.80
- Average True Range (ATR)
- XBP 0.16
- INKT 0.05
- MACD
- XBP 0.05
- INKT 0.01
- Stochastic Oscillator
- XBP 69.58
- INKT 62.60
About XBP XBP Europe Holdings Inc.
XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.